Found: 75
Select item for more details and to access through your institution.
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 103, doi. 10.1007/s10637-017-0530-4
- By:
- Publication type:
- Article
A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 1, p. 47, doi. 10.1007/s10637-016-0391-2
- By:
- Publication type:
- Article
A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 4, p. 439, doi. 10.1007/s10637-016-0348-5
- By:
- Publication type:
- Article
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 2, p. 425, doi. 10.1007/s10637-012-9862-2
- By:
- Publication type:
- Article
Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1074, doi. 10.1007/s10637-011-9639-z
- By:
- Publication type:
- Article
A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
A pilot phase II trial of all- trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1482, doi. 10.1007/s10637-010-9478-3
- By:
- Publication type:
- Article
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 3, p. 489, doi. 10.1007/s10637-009-9376-8
- By:
- Publication type:
- Article
Current concepts and approaches to merkel cell carcinoma.
- Published in:
- Archives of Dermatological Research, 2021, v. 313, n. 3, p. 129, doi. 10.1007/s00403-020-02107-9
- By:
- Publication type:
- Article
Acral lentiginous melanoma of the foot misdiagnosed as a traumatic ulcer. A cautionary case.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Acral Lentiginous Melanoma of the Foot Misdiagnosed as a Traumatic Ulcer.
- Published in:
- Journal of the American Podiatric Medical Association, 2015, v. 105, n. 2, p. 189, doi. 10.7547/0003-0538-105.2.189
- By:
- Publication type:
- Article
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 450, p. 1, doi. 10.1126/scitranslmed.aar3342
- By:
- Publication type:
- Article
KIT as a Therapeutic Target in Metastatic Melanoma.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 305, n. 22, p. 2327, doi. 10.1001/jama.2011.746
- By:
- Publication type:
- Article
Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00974-z
- By:
- Publication type:
- Article
Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients.
- Published in:
- Genome Medicine, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13073-019-0672-4
- By:
- Publication type:
- Article
Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era?
- Published in:
- Journal of Neuro-Oncology, 2022, v. 158, n. 3, p. 471, doi. 10.1007/s11060-022-04036-1
- By:
- Publication type:
- Article
Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 127, n. 3, p. 607, doi. 10.1007/s11060-016-2072-6
- By:
- Publication type:
- Article
Vemurafenib and radiation therapy in melanoma brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 113, n. 3, p. 411, doi. 10.1007/s11060-013-1127-1
- By:
- Publication type:
- Article
Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma.
- Published in:
- Chemotherapy (0009-3157), 2009, v. 55, n. 4, p. 221, doi. 10.1159/000219435
- By:
- Publication type:
- Article
Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
- Published in:
- Journal of Surgical Oncology, 2020, v. 122, n. 3, p. 555, doi. 10.1002/jso.25987
- By:
- Publication type:
- Article
Management of Melanoma during Pregnancy: A Case Series of 11 Women Treated at NYU Langone Health.
- Published in:
- Oncology, 2020, v. 98, n. 12, p. 847, doi. 10.1159/000506811
- By:
- Publication type:
- Article
Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature.
- Published in:
- Oncology, 2017, v. 93, n. 4, p. 249, doi. 10.1159/000478050
- By:
- Publication type:
- Article
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care.
- Published in:
- Oncology, 2017, v. 93, n. 3, p. 164, doi. 10.1159/000475715
- By:
- Publication type:
- Article
Impact of Age on the Management of Primary Melanoma Patients.
- Published in:
- Oncology, 2013, v. 85, n. 3, p. 173, doi. 10.1159/000351499
- By:
- Publication type:
- Article
Enrollment in Clinical Trials Correlates with Improved Survival in Metastatic Melanoma.
- Published in:
- Oncology, 2011, v. 81, n. 5/6, p. 403, doi. 10.1159/000335000
- By:
- Publication type:
- Article
A High Proliferative Index of Recurrent Melanoma Is Associated with Worse Survival.
- Published in:
- Oncology, 2011, v. 80, n. 3/4, p. 181, doi. 10.1159/000328518
- By:
- Publication type:
- Article
Decreased cytotoxic T cells and TCR clonality in organ transplant recipients with squamous cell carcinoma.
- Published in:
- NPJ Precision Oncology, 2020, v. 4, n. 1, p. 1, doi. 10.1038/s41698-020-0119-9
- By:
- Publication type:
- Article
Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Identification of Metastasis-Suppressive microRNAs in Primary Melanoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 3, p. 1, doi. 10.1093/jnci/dju494
- By:
- Publication type:
- Article
Identification of metastasis-suppressive microRNAs in primary melanoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 1, p. 157, doi. 10.1016/j.molonc.2015.09.005
- By:
- Publication type:
- Article
Mucosal Melanomas: A Case-Based Review of the Literature.
- Published in:
- Oncologist, 2010, v. 15, n. 7, p. 772, doi. 10.1634/theoncologist.2010-0067
- By:
- Publication type:
- Article
Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM).
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46665-z
- By:
- Publication type:
- Article
Intra- and Inter-Tumor Heterogeneity of BRAF<sup>V600E</sup>Mutations in Primary and Metastatic Melanoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029336
- By:
- Publication type:
- Article
The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025264
- By:
- Publication type:
- Article
A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates.
- Published in:
- PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0015588
- By:
- Publication type:
- Article
A Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) in Patients with Metastatic Melanoma.
- Published in:
- PLoS ONE, 2010, v. 5, n. 1, p. 1, doi. 10.1371/journal.pone.0008714
- By:
- Publication type:
- Article
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma.
- Published in:
- 2015
- By:
- Publication type:
- Abstract
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 316, doi. 10.1186/s12967-014-0342-7
- By:
- Publication type:
- Article
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Melanoma risk loci as determinants of melanoma recurrence and survival.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-279
- By:
- Publication type:
- Article
Melanoma risk loci as determinants of melanoma recurrence and survival.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Serum microRNAs as biomarkers for recurrence in melanoma.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 155, doi. 10.1186/1479-5876-10-155
- By:
- Publication type:
- Article
Incidence of the V600K mutation amongmelanoma patients with BRAF mutations, andpotential therapeutic response to the specificBRAF inhibitor PLX4032.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 67, doi. 10.1186/1479-5876-8-67
- By:
- Publication type:
- Article
Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma.
- Published in:
- Journal of Translational Medicine, 2007, v. 5, p. 2, doi. 10.1186/1479-5876-5-2
- By:
- Publication type:
- Article
Significant Survival Improvements for Patients with Melanoma Brain Metastases: Can We Reach Cure in the Current Era?
- Published in:
- Journal of Radiosurgery & SBRT, 2022, v. 8, p. 25
- By:
- Publication type:
- Article
Clinical relevance of SKP2 alterations in metastatic melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2011, v. 24, n. 1, p. 197, doi. 10.1111/j.1755-148X.2010.00784.x
- By:
- Publication type:
- Article